Babal Kant Jha

Person

Cleveland, OH, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antitumor TET2 modulating compounds
- Patent number 11,865,104
- Issue date Jan 9, 2024
- The Cleveland Clinic Foundation
- Jaroslaw Maciejewski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antitumor derivatives for differentiation therapy
- Patent number 10,370,373
- Issue date Aug 6, 2019
- The Cleveland Clinic Foundation
- Yogenthiran Saunthararajah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antitumor derivatives for differentiation therapy
- Patent number 9,926,316
- Issue date Mar 27, 2018
- The Cleveland Clinic Foundation
- Yogenthiran Saunthararajah
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTITUMOR TET2 MODULATING COMPOUNDS
- Publication number 20240307347
- Publication date Sep 19, 2024
- The Cleveland Clinic Foundation
- Jaroslaw Maciejewski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF RNA VIRUS INFECTION WITH A CYTIDINE
- Publication number 20240197766
- Publication date Jun 20, 2024
- The Cleveland Clinic Foundation
- Yogen Saunthararajah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SMALL MOLECULE NICOTINAMIDE ADENINE DINUCLEOTIDE MODULATORS
- Publication number 20230331663
- Publication date Oct 19, 2023
- The Cleveland Clinic Foundation
- Babal Kant Jha
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIOAVAILABLE PROTEIN DISULFIDE ISOMERASE INHIBITORS
- Publication number 20230312552
- Publication date Oct 5, 2023
- Babal K. Jha
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTITUMOR TET2 MODULATING COMPOUNDS
- Publication number 20200306221
- Publication date Oct 1, 2020
- The Cleveland Clinic Foundation
- Jaroslaw Maciejewski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTITUMOR DERIVATIVES FOR DIFFERENTIATION THERAPY
- Publication number 20180194764
- Publication date Jul 12, 2018
- The Cleveland Clinic Foundation
- Yogenthiran Saunthararajah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTITUMOR NAPHTHALENYL BENZAMIDE DERIVATIVES
- Publication number 20170057910
- Publication date Mar 2, 2017
- The Cleveland Clinic Foundation
- Frederic J. Reu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION VIROTHERAPY FOR CANCER
- Publication number 20130071432
- Publication date Mar 21, 2013
- The Cleveland Clinic Foundation
- Robert Silverman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Babal Kant Jha

Person

Patents Grantslast 30 patents

Antitumor TET2 modulating compounds

Antitumor derivatives for differentiation therapy

Antitumor derivatives for differentiation therapy

Patents Applicationslast 30 patents

ANTITUMOR TET2 MODULATING COMPOUNDS

TREATMENT OF RNA VIRUS INFECTION WITH A CYTIDINE

SMALL MOLECULE NICOTINAMIDE ADENINE DINUCLEOTIDE MODULATORS

BIOAVAILABLE PROTEIN DISULFIDE ISOMERASE INHIBITORS

ANTITUMOR TET2 MODULATING COMPOUNDS

ANTITUMOR DERIVATIVES FOR DIFFERENTIATION THERAPY

ANTITUMOR NAPHTHALENYL BENZAMIDE DERIVATIVES

COMBINATION VIROTHERAPY FOR CANCER